Evidence map›Paper›PMID 42075719›Full record

ArticlePathogens (Basel, Switzerland)2026

Time Course Characterization of Protective Immune Responses Following BCG Vaccination in BALB/c Mice.

Hee Ho Kim, Kwangwook Kim, Min Jung Kim, Ye Jin Yang, Eun Bee Choi, Ji Woong Heo, Seo Young Moon, Heeji Lim, Yookyoung Lee, In-Ohk Ouh and 1 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hee Ho KimCollege of Veterinary Medicine, Gyeongsang National University, Gazwa, Jinju 52828, Republic of Korea.
Kwangwook KimDivision of Vaccine Development Coordination, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.ORCID 0000-0002-7200-871X
Min Jung KimCollege of Veterinary Medicine, Gyeongsang National University, Gazwa, Jinju 52828, Republic of Korea.
Ye Jin YangCollege of Veterinary Medicine, Gyeongsang National University, Gazwa, Jinju 52828, Republic of Korea.
Eun Bee ChoiDivision of Vaccine Development Coordination, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.
Ji Woong HeoCollege of Veterinary Medicine, Gyeongsang National University, Gazwa, Jinju 52828, Republic of Korea.
Seo Young MoonDivision of Vaccine Development Coordination, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.
Heeji LimDivision of Vaccine Development Coordination, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.ORCID 0000-0003-3546-9477
Yookyoung LeeDivision of Vaccine Development Coordination, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.
In-Ohk OuhDivision of Vaccine Development Coordination, Center for Vaccine Research National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.
Kwang Il ParkCollege of Veterinary Medicine, Gyeongsang National University, Gazwa, Jinju 52828, Republic of Korea.ORCID 0000-0002-0199-8090

Funding

Korea Disease Control and Prevention Agency 6600-6634-313National Research Foundation of Korea RS-2022-NR075631
6 · The paper itself

Abstract

BACKGROUND/

objectivesTuberculosis (TB) remains a major global health challenge, requiring standardized animal models to evaluate vaccine-induced immune responses. This study characterized time-dependent immune responses following Bacillus Calmette-Guérin (BCG) vaccination in BALB/c mice.

methodsBALB/c mice were vaccinated with BCG, and the immune responses and protective efficacy were evaluated at 4, 6, and 8 weeks post-immunization. The cytokine expression in serum, lung, and spleen tissues was analyzed using ELISA, quantitative PCR, and immunohistochemistry. Protective efficacy was assessed via colony-forming unit (CFU) enumeration and the immunohistochemical detection of Mycobacterium TB after aerosol challenge.

resultsThe BCG vaccination induced time-dependent and tissue-specific cytokine responses. Pulmonary IL-1β and splenic IFN-γ levels were significantly increased four weeks post-vaccination. At 8 weeks, serum IL-2, pulmonary IL-2, and TNF-α were significantly increased, whereas no significant changes in cytokines were observed at 6 weeks. After the challenge, BCG-vaccinated mice exhibited reduced bacterial burdens compared with controls, but the differences among the 4-, 6-, and 8-week groups were modest.

conclusionsImmune responses became detectable starting four weeks after BCG vaccination, with temporal differences observed in cytokine expression. Week 8 may serve as a reference point for monitoring cytokine dynamics rather than as an optimal time for protection.

Indexed as

BCG VaccineTuberculosisAnimalsCytokinesDisease Models, AnimalFemaleLungMiceMice, Inbred BALB CMycobacterium tuberculosisSpleenTime FactorsVaccinationBCG VaccineCytokinesBacillus Calmette–Guérin (BCG)immune responseimmunization periodtuberculosis

Identifiers

PMID42075719
PMCPMC13118547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.